Rockwell Medical (RMTI) vs TherapeuticsMD (TXMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TherapeuticsMD (TXMD) has outperformed Rockwell Medical (RMTI) over the past year, gaining 89.6% versus a loss of 33.7%. Over five years, RMTI leads with a -87.8% price change compared with -94.4% for TXMD. Rockwell Medical is the larger company by market cap ($32.3 million vs $23.3 million), about 1.4 times the size.
On valuation, TherapeuticsMD trades at a lower forward P/E (5.7x vs 114.6x for Rockwell Medical).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RMTI | TXMD |
|---|---|---|
| Share price | $8.02 | $2.01 |
| Market cap | $32.32M | $23.26M |
| 1-day change | -2.43% | +0.50% |
| YTD return | -3.37% | +23.31% |
| 1-year return | -33.72% | +89.62% |
| 5-year return | -87.85% | -94.42% |
| Forward P/E | 114.57 | 5.74 |
| EPS (TTM) | $-1.34 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.90 | $2.95 |
| 52-week low | $4.89 | $1.03 |
| Distance from 52-week high | -37.83% | -31.86% |
| Analyst consensus | none | — |
| Avg. price target upside | +149.38% | — |
| Average volume | 26.80K | 23.94K |
| Shares outstanding | 4.03M | 11.57M |
| Employees | 157 | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TXMD has outperformed RMTI by 123.3 percentage points over the past year.
About Rockwell Medical
RMTI stock →Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.
Healthcare · Drug Manufacturers - Specialty & Generic · 157 employees
About TherapeuticsMD
TXMD stock →TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 1 employees
RMTI vs TXMD FAQ
Which is bigger, Rockwell Medical or TherapeuticsMD?
Rockwell Medical (RMTI) is larger, with a market capitalization of $32.32M compared with $23.26M for TherapeuticsMD (TXMD).
Which stock has performed better over the past year, RMTI or TXMD?
TXMD returned +89.62% over the past 12 months, compared with -33.72% for RMTI (price return, excluding dividends). Past performance does not predict future results.
Are Rockwell Medical and TherapeuticsMD in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.